RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Star Combo Pharma Stock

Star Combo Pharma P/E 2024

Star Combo Pharma P/E

21.69

Ticker

S66.AX

ISIN

AU0000004798

As of Oct 1, 2024, Star Combo Pharma's P/E ratio was 21.69, a -684.64% change from the -3.71 P/E ratio recorded in the previous year.

The Star Combo Pharma P/E history

Star Combo Pharma Aktienanalyse

What does Star Combo Pharma do?

Star Combo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Star Combo Pharma's P/E Ratio

The Price to Earnings (P/E) Ratio of Star Combo Pharma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Star Combo Pharma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Star Combo Pharma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Star Combo Pharma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Star Combo Pharma stock

What is the price-to-earnings ratio of Star Combo Pharma?

The price-earnings ratio of Star Combo Pharma is currently 21.69.

How has the price-earnings ratio of Star Combo Pharma changed compared to last year?

The price-to-earnings ratio of Star Combo Pharma has increased by -684.64% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Star Combo Pharma high compared to other companies?

Yes, the price-to-earnings ratio of Star Combo Pharma is high compared to other companies.

How does an increase in the price-earnings ratio of Star Combo Pharma affect the company?

An increase in the price-earnings ratio of Star Combo Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Star Combo Pharma affect the company?

A decrease in the price-earnings ratio of Star Combo Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Star Combo Pharma?

Some factors that influence the price-earnings ratio of Star Combo Pharma are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Star Combo Pharma pay?

Over the past 12 months, Star Combo Pharma paid a dividend of 0 AUD . This corresponds to a dividend yield of about 3.18 %. For the coming 12 months, Star Combo Pharma is expected to pay a dividend of 0 AUD.

What is the dividend yield of Star Combo Pharma?

The current dividend yield of Star Combo Pharma is 3.18 %.

When does Star Combo Pharma pay dividends?

Star Combo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Star Combo Pharma?

Star Combo Pharma paid dividends every year for the past 1 years.

What is the dividend of Star Combo Pharma?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 3.18 %.

In which sector is Star Combo Pharma located?

Star Combo Pharma is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Star Combo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Star Combo Pharma from 10/31/2024 amounting to 0.005 AUD, you needed to have the stock in your portfolio before the ex-date on 10/14/2024.

When did Star Combo Pharma pay the last dividend?

The last dividend was paid out on 10/31/2024.

What was the dividend of Star Combo Pharma in the year 2023?

In the year 2023, Star Combo Pharma distributed 0 AUD as dividends.

In which currency does Star Combo Pharma pay out the dividend?

The dividends of Star Combo Pharma are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Star Combo Pharma

Our stock analysis for Star Combo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Star Combo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.